Novavax executives have seized the opportunity to bank profits and capitalize on the 3,000% rally in the stock’s share price as speculators continue …
Novavax (NVAX) has signed a non-binding heads of terms document with the Australian Government to supply 40 million doses of the company’s COVID-19 …
Shares of Novavax are down more than 6% as the drugmaker delayed the start of the US late-stage trial of its COVID-19 vaccine …
Shares in Novavax are surging almost 8% in the pre-market session after the biotech company said additional data from the Phase 1/2 clinical …
Novavax reached an agreement in principle with the Government of Canada to supply up to 76 million doses of NVX-CoV2373, its COVID-19 vaccine candidate. Novavax …
Late-stage biotech Novavax (NVAX) has announced the beginning of a Phase 2b clinical trial in South Africa to evaluate the efficacy of NVX-CoV2373, Novavax’ COVID-19 …
Novavax said on Friday that the US drug developer has entered into a purchase agreement with the UK government for the supply of …
Shares in Novavax jumped more than 7% after the biotech company said South Korea’s SK bioscience will manufacture the antigen component of its …
Shares in Novavax (NVAX) rose 5% in Monday’s trading after the late-stage biotech announced positive second quarter earning results. However the stock subsequently …
Novavax announced a partnership with Takeda Pharmaceutical to sell up to 250 million doses of NVX‑CoV2373, its COVID-19 vaccine candidate, a year in …
